Rating History for Royalty Pharma (RPRX) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for RPRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/13/2026 Asad Haider Maintain Buy
(N/A)		 51.00
(45.00)		  
 		   Details